BIONET Corp. (1784.TWO)

TWD 79.5

(-3.52%)

Operating Expenses Summary of BIONET Corp.

  • BIONET Corp.'s latest annual operating expenses in 2023 was 553.58 Million TWD , up 14.46% from previous year.
  • BIONET Corp.'s latest quarterly operating expenses in 2024 Q2 was 144.04 Million TWD , up 2.64% from previous quarter.
  • BIONET Corp. reported a annual operating expenses of 482.25 Million TWD in annual operating expenses 2022, up 2.27% from previous year.
  • BIONET Corp. reported a annual operating expenses of 471.53 Million TWD in annual operating expenses 2021, up 13.63% from previous year.
  • BIONET Corp. reported a quarterly operating expenses of 144.04 Million TWD for 2024 Q2, up 2.64% from previous quarter.
  • BIONET Corp. reported a quarterly operating expenses of 148.44 Million TWD for 2023 Q4, down -0.75% from previous quarter.

Annual Operating Expenses Chart of BIONET Corp. (2023 - 2019)

Historical Annual Operating Expenses of BIONET Corp. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 553.58 Million TWD 14.46%
2022 482.25 Million TWD 2.27%
2021 471.53 Million TWD 13.63%
2020 414.95 Million TWD 0.39%
2019 413.35 Million TWD 0.0%

Peer Operating Expenses Comparison of BIONET Corp.

Name Operating Expenses Operating Expenses Difference
DIVA Laboratories, Ltd. 158.62 Million TWD -248.998%
Genetics Generation Advancement Corp. 218.25 Million TWD -153.642%
Welgene Biotech Co.,Ltd. 123.97 Million TWD -346.529%
Puriblood Medical Co., Ltd. 56.92 Million TWD -872.462%
TFBS Bioscience Inc. 77.82 Million TWD -611.282%